{"id":53046,"date":"2021-04-08T00:00:00","date_gmt":"2021-04-08T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2021\/04\/08\/oral-covid-19-vaccine-being-tested\/"},"modified":"2021-04-09T17:11:01","modified_gmt":"2021-04-09T17:11:01","slug":"oral-covid-19-vaccine-being-tested","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2021\/04\/08\/oral-covid-19-vaccine-being-tested\/","title":{"rendered":"Oral COVID-19 Vaccine Being Tested"},"content":{"rendered":"<h3>\n<p>T cell oral vaccine targets the globe in the middle of the virus, a part less prone to mutation<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>THURSDAY, April 8, 2021 (HealthDay News) &#8212; California researchers are testing whether an oral vaccine offers similar or better protection than current COVID-19 shots.<\/p>\n<p>The capsule-delivered vaccine under development at the Chan Soon-Shiong Research Institute in El Segundo is being tested in healthy volunteers, <em>CBS News<\/em> reported.<\/p>\n<p>Existing vaccines promote production of antibodies to the spike protein on the surface of the coronavirus that causes COVID-19, but the ImmunityBio T cell oral vaccine targets the globe in the middle of the virus, a part that is less prone to mutation, according to scientists. &#8220;And the value of doing so is that we generate killer T cells,&#8221; ImmunityBio founder and Executive Chairman Patrick Soon-Shiong, M.D., told <em>CBS News<\/em>.<\/p>\n<p>The ImmunityBio researchers believe they may be able to create long-term protection by generating both antibodies and killer T cells.<\/p>\n<p><a href=\"https:\/\/www.cbsnews.com\/news\/covid-19-vaccine-oral-testing-los-angeles\/\" target=\"_blank\" rel=\"noopener\"><em>CBS News<\/em> Article<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2021 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>T cell oral vaccine targets the globe in the middle of the virus, a part less prone to mutation<\/p>\n","protected":false},"author":6,"featured_media":53203,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-53046","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/53046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=53046"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/53046\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/53203"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=53046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=53046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=53046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}